Richard Pzena's position in United Therapeutics is currently worth $554 Thousand. That's 0.00% of their equity portfolio (142nd largest holding). The first United Therapeutics trade was made in Q2 2020. Since then Richard Pzena bought shares seven more times and sold shares on six occasions. The stake costed the investor $505 Thousand, netting the investor a gain of 9.8% so far.